microbeПроблемы особо опасных инфекцийProblems of Particularly Dangerous Infections0370-10692658-719XRussian Research Anti-Plague Institute “Microbe”10.21055/0370-1069-2012-4-29-32microbe-866Research ArticleЭПИДЕМИОЛОГИЯ, БИОБЕЗОПАСНОСТЬEPIDEMIOLOGY, BIOSAFETYОценка эффективности обеспечения биологической безопасности работ со штаммами фиксированного вируса бешенства при производстве антирабического иммуно­глобулинаEvaluation of the Effectiveness as to the Provision of Biological Safety of Works with Fixed Rabies Virus in the Process of Anti-Rabies Immunoglobulin ManufacturingНикифоровА. К.NikiforovA. K.rusrapi@microbe.ruАбрамоваЕ. Г.AbramovaE. G.rusrapi@microbe.ruЕреминС. А.EreminS. A.rusrapi@microbe.ruЛяпинМ. Н.LyapinM. N.rusrapi@microbe.ruРоссийский научно-исследовательский противочумный институт «Микроб»РоссияRussian Research Anti-Plague Institute “Microbe”Russian Federation20122008201204(114)2932Copyright © Никифоров А.К., Абрамова Е.Г., Еремин С.А., Ляпин М.Н., 20122012Никифоров А.К., Абрамова Е.Г., Еремин С.А., Ляпин М.Н.Nikiforov A.K., Abramova E.G., Eremin S.A., Lyapin M.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.microbe.ru/jour/article/view/866

Проведен анализ работы со штаммами фиксированного вируса бешенства в условиях производства антирабического иммуноглобулина. Дана оценка эффективности разработанной системы биологической безопасности, обеспечивающей безопасное производство антирабического иммуноглобулина на протяжении 12 лет.

Analyzed is the performance of works with the strains of fixed rabies virus under the conditions of anti-rabies immunoglobulin manufacturing. Evaluated is the effectiveness of the established system for the provision of biological safety, which has allowed for safe manufacturing of anti-rabies immunoglobulin within the period of 12 years.

биологическая безопасностьфиксированный вирус бешенстваоценка рискаbiological safetyfixed rabies virusrisk assessmentReferencesНикифоров А.К., Дятлов И.А., Еремин С.А., Волох О.А., Ляпин М.Н. Оценка риска как основа обеспечения биобезопасности работ с производственными штаммами фиксированного вируса бешенства. Пробл. особо опасных инф. 2006; 2(92):38–40.Nikiforov A.K., Dyatlov I.A., Yeremin S.A., Volokh O.A., Lyapin M.N. [Qualification of the risks as the basis for assuring biologically safe handling of the rabies virus production strains]. Probl. Osobo Opasn. Infek. 2006; (92):38–40.Селимов М.А., Морогова В.М. Феноловые лиофилизированные вакцины из мозговой ткани овец. В кн.: Методы лабораторных исследований по бешенству. Женева: ВОЗ; 1975. С. 201–3.Selimov M.A., Morogova V.M. [Phenol lyophilized vaccines obtained from the brain tissue of sheep]. In: [Methods of laboratory investigations on rabies virus]. Geneva: WHO; 1975. P. 201–3.Селимов М.А. Бешенство. М.: Медицина; 1978. 336 с.Selimov M.A. [Rabies]. M.: Meditsina; 1978. 336 p.Biosafety in Microbiological and Biomedical Laboratories (BMBL). 5th edition. U.S. Department of Health and Human Services; Public Health Service; Centers for Disease Control and Prevention; National Institutes of Health; 2007. 360 p.Biosafety in Microbiological and Biomedical Laboratories (BMBL). 5th edition. U.S. Department of Health and Human Services; Public Health Service; Centers for Disease Control and Prevention; National Institutes of Health; 2007. 360 p.Fundamentals of biosafety in laboratories. 3rd edition. Department of Foreign Affairs and International Trade (Canada); 2004. 108 p.Fundamentals of biosafety in laboratories. 3rd edition. Department of Foreign Affairs and International Trade (Canada); 2004. 108 p.Нarding A.L., Byers K.B. Epidemiology of Laboratory-Associated Infection. In: Fleming D.O., Hunt D.L. Biological Safety: principles and practices. 3rd ed. Washington DC: ASM Press; 2000. P. 35–54.Нarding A.L., Byers K.B. Epidemiology of Laboratory-Associated Infection. In: Fleming D.O., Hunt D.L. Biological Safety: principles and practices. 3rd ed. Washington DC: ASM Press; 2000. P. 35–54.Laboratory biosafety manual. 3rd edition. Geneva: WHO; 2004. 190 p.Laboratory biosafety manual. 3rd edition. Geneva: WHO; 2004. 190 p.Meslin F.-X., Kaplan V.V., Кoprowsky H., editors. Laboratory techniques in rabies. Geneva: WHO; 1996. 469 p.Meslin F.-X., Kaplan V.V., Кoprowsky H., editors. Laboratory techniques in rabies. Geneva: WHO; 1996. 469 p.Pike R.M., Sulkin S.E., Schulze M.L. Continuing importance of laboratory-acquired infections. Am. J. Pub. Hlth. 1965; 55:190–9.Pike R.M., Sulkin S.E., Schulze M.L. Continuing importance of laboratory-acquired infections. Am. J. Pub. Hlth. 1965; 55:190–9.Рike R.M. Laboratory-associated infections: summary and analysis of 3921 cases. Health. Lab. Sci. 1976; 13:105–14.Рike R.M. Laboratory-associated infections: summary and analysis of 3921 cases. Health. Lab. Sci. 1976; 13:105–14.Pike R.M. Past and present hazards of working with infectious agents. Arch. Pathol. Lab. Med. 1978; 102:333–6.Pike R.M. Past and present hazards of working with infectious agents. Arch. Pathol. Lab. Med. 1978; 102:333–6.Pike R.M. Laboratory-associated infections: incidence, fatalities, causes, and prevention. Annu. Rev. Microbiol. 1979; 33: 41–66.Pike R.M. Laboratory-associated infections: incidence, fatalities, causes, and prevention. Annu. Rev. Microbiol. 1979; 33: 41–66.Richardson J.H., Barkley W.E., editors. Biosafety in microbiological and biomedical laboratories. 1st ed. Washington, DC; 1984.Richardson J.H., Barkley W.E., editors. Biosafety in microbiological and biomedical laboratories. 1st ed. Washington, DC; 1984.Sulkin S.E., Pike R.M. Survey of laboratory-acquired infections. Am. J. Pub. Hlth. 1951; 41:769–81.Sulkin S.E., Pike R.M. Survey of laboratory-acquired infections. Am. J. Pub. Hlth. 1951; 41:769–81.

The authors declare that there are no conflicts of interest present.